Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2025-12-25 @ 2:38 PM
Study NCT ID:
NCT00412750
Status:
TERMINATED
Last Update Posted:
2011-07-13
First Post:
2006-12-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12
Start Date Type:
None
Primary Completion Date:
2009-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-15
First Submit QC Date:
None
Study First Post Date:
2006-12-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-12-02
Results First Submit QC Date:
None
Results First Post Date:
2011-07-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-06-14
Last Update Post Date:
2011-07-13
Last Update Post Date Type:
ESTIMATED